Efficacy and Safety of Botulinum Toxin Type B (Myobloc®) for the Treatment of Sialorrhea in Parkinson's Disease (PD)

被引：0
|
作者：
Salazar-Grueso, Edgar F.
Hogan, Patrick
Pagan, Fernando
Reinhard, Sharon
Pappert, Eric
Birmingham, William
机构：
来源：
NEUROLOGY | 2009年 / 72卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A26 / A26
页数：1
相关论文
共 50 条
  • [31] Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients
    Gil, Ramon A.
    Hwynn, Nelson
    Fabian, Thomas
    Joseph, Sovi
    Fernandez, Hubert H.
    PARKINSONISM & RELATED DISORDERS, 2011, 17 (04) : 285 - 287
  • [32] Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease
    Contarino, Maria Fiorella
    Pomipili, Maurizio
    Tittoto, Paola
    Vanacore, Nicola
    Sabatelli, Mario
    Cedrone, Augusto
    Rapaccini, Gian Ludovico
    Gasbarrini, Giovanni
    Tonali, Pietro Attilio
    Bentivoglio, Anna Rita
    PARKINSONISM & RELATED DISORDERS, 2007, 13 (05) : 299 - 303
  • [33] LONG-TERM SAFETY AND EFFICACY OF MYOBLOC® (RIMABOTULINUMTOXINB) IN THE TREATMENT OF ADULT SIALORRHEA
    Isaacson, Stuart
    Lew, Mark
    Dashtipour, Khashayar
    Chary, Dilip
    Clinch, Thomas
    Pahwa, Rajesh
    TOXICON, 2018, 156 : S48 - S48
  • [34] Effectiveness of the Botulinum Toxin for Treating Sialorrhea in Patients with Parkinson's Disease: A Systematic Review
    Antonio Ruiz-Roca, Juan
    Pons-Fuster, Eduardo
    Lopez-Jornet, Pia
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (03):
  • [35] A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease
    Ondo, WG
    Hunter, C
    Moore, W
    NEUROLOGY, 2004, 62 (01) : 37 - 40
  • [36] Rimabotulinumtoxin B for the treatment of sialorrhea in Parkinson's disease
    Alvarez, M. V.
    Grogan, P. M.
    Alvarez, M.
    MOVEMENT DISORDERS, 2013, 28 : S92 - S93
  • [37] Botulinum toxin type B (MyoBloc) in the management of hyperkinetic facial lines
    Ramirez, AL
    Reeck, J
    Maas, CS
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2002, 126 (05) : 459 - 467
  • [38] Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (Botulinum toxin type B) for the treatment of palmar hyperhidrosis
    Baumann, L
    Slezinger, A
    Halem, M
    Vujevich, J
    Mallin, K
    Charles, C
    Martin, LK
    Black, L
    Bryde, J
    DERMATOLOGIC SURGERY, 2005, 31 (03) : 263 - 270
  • [39] Botulinum toxin type B for sialorrhea in children with cerebral palsy
    Reddihough, Dinah
    Graham, H. Kerr
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2011, 53 (06): : 488 - 489
  • [40] Stability of Myobloc™/Neurobloc™ (botulinum toxin type B) in preserved saline
    Setler, P
    Burke, D
    Callaway, J
    Wang, C
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R40 - R40
12345